218 related articles for article (PubMed ID: 25818172)
1. Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice.
Garofalo S; D'Alessandro G; Chece G; Brau F; Maggi L; Rosa A; Porzia A; Mainiero F; Esposito V; Lauro C; Benigni G; Bernardini G; Santoni A; Limatola C
Nat Commun; 2015 Mar; 6():6623. PubMed ID: 25818172
[TBL] [Abstract][Full Text] [Related]
2. Enriched Environment Cues Suggest a New Strategy to Counteract Glioma: Engineered rAAV2-IL-15 Microglia Modulate the Tumor Microenvironment.
Mormino A; Bernardini G; Cocozza G; Corbi N; Passananti C; Santoni A; Limatola C; Garofalo S
Front Immunol; 2021; 12():730128. PubMed ID: 34552593
[TBL] [Abstract][Full Text] [Related]
3. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
4. The Glycoside Oleandrin Reduces Glioma Growth with Direct and Indirect Effects on Tumor Cells.
Garofalo S; Grimaldi A; Chece G; Porzia A; Morrone S; Mainiero F; D'Alessandro G; Esposito V; Cortese B; Di Angelantonio S; Trettel F; Limatola C
J Neurosci; 2017 Apr; 37(14):3926-3939. PubMed ID: 28292827
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
[TBL] [Abstract][Full Text] [Related]
6. A dialog between glioma and microglia that promotes tumor invasiveness through the CCL2/CCR2/interleukin-6 axis.
Zhang J; Sarkar S; Cua R; Zhou Y; Hader W; Yong VW
Carcinogenesis; 2012 Feb; 33(2):312-9. PubMed ID: 22159219
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice.
D'Alessandro G; Antonangeli F; Marrocco F; Porzia A; Lauro C; Santoni A; Limatola C
Eur J Immunol; 2020 May; 50(5):705-711. PubMed ID: 32034922
[TBL] [Abstract][Full Text] [Related]
8. Environmental stimuli shape microglial plasticity in glioma.
Garofalo S; Porzia A; Mainiero F; Di Angelantonio S; Cortese B; Basilico B; Pagani F; Cignitti G; Chece G; Maggio R; Tremblay ME; Savage J; Bisht K; Esposito V; Bernardini G; Seyfried T; Mieczkowski J; Stepniak K; Kaminska B; Santoni A; Limatola C
Elife; 2017 Dec; 6():. PubMed ID: 29286001
[TBL] [Abstract][Full Text] [Related]
9. Prolonged microgliosis in the rhesus monkey central nervous system after traumatic brain injury.
Nagamoto-Combs K; McNeal DW; Morecraft RJ; Combs CK
J Neurotrauma; 2007 Nov; 24(11):1719-42. PubMed ID: 18001202
[TBL] [Abstract][Full Text] [Related]
10. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.
Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB
Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224
[TBL] [Abstract][Full Text] [Related]
11. TrkB-T1 regulates the RhoA signaling and actin cytoskeleton in glioma cells.
Ohira K; Homma KJ; Hirai H; Nakamura S; Hayashi M
Biochem Biophys Res Commun; 2006 Apr; 342(3):867-74. PubMed ID: 16500620
[TBL] [Abstract][Full Text] [Related]
12. Enriched environment enhances NK cell maturation through hypothalamic BDNF in male mice.
Mansour AG; Xiao R; Bergin SM; Huang W; Chrislip LA; Zhang J; Ali S; Queen NJ; Caligiuri MA; Cao L
Eur J Immunol; 2021 Mar; 51(3):557-566. PubMed ID: 33169371
[TBL] [Abstract][Full Text] [Related]
13. Differential activation of dendritic cells by nerve growth factor and brain-derived neurotrophic factor.
Noga O; Peiser M; Altenähr M; Knieling H; Wanner R; Hanf G; Grosse R; Suttorp N
Clin Exp Allergy; 2007 Nov; 37(11):1701-8. PubMed ID: 17892512
[TBL] [Abstract][Full Text] [Related]
14. IL-15 and macrophage secretory factors facilitate immune activation of neonatal natural killer cells by lipoteichoic acid.
Cheng SF; Ho JW; Chan KY; Leung TY; Lam HS; Fong ON; Li K; Ng PC
Cytokine; 2013 Feb; 61(2):499-505. PubMed ID: 23201488
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18-stimulated macrophages mediated by interferon-gamma-regulated nitric oxide.
Kito T; Kuroda E; Yokota A; Yamashita U
J Neurosurg; 2003 Feb; 98(2):385-92. PubMed ID: 12593627
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
[TBL] [Abstract][Full Text] [Related]
17. Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats.
Sasaki A; Yokoo H; Tanaka Y; Homma T; Nakazato Y; Ohgaki H
Neuropathology; 2013 Oct; 33(5):505-14. PubMed ID: 23331472
[TBL] [Abstract][Full Text] [Related]
18. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
19. Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice.
Di Carlo E; Meazza R; Basso S; Rosso O; Comes A; Gaggero A; Musiani P; Santi L; Ferrini S
J Pathol; 2000 Jun; 191(2):193-201. PubMed ID: 10861581
[TBL] [Abstract][Full Text] [Related]
20. Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways.
Mattiola I; Pesant M; Tentorio PF; Molgora M; Marcenaro E; Lugli E; Locati M; Mavilio D
J Immunol; 2015 Sep; 195(6):2818-28. PubMed ID: 26276870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
